Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-02-07 @ 10:12 AM
Study NCT ID:
NCT00122460
Status:
COMPLETED
Last Update Posted:
2014-07-23
First Post:
2005-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization: